Verastem, Inc.

NASDAQ:VSTM

Biotechnology

Healthcare
$7.41 -0.00%

-$0.00 today

Market cap
$933.77M
Beta
0.27
P/E (TTM)
-2.1
EPS (TTM)
-$1.97
52W Low $3.55High $11.25

Volume 2.87M

Average 2.58M

Income Statement

Follow revenue through to earnings.

Revenue

$30.91M

FY 2025 · Annual

+209.1% YoY

Operating Income

-$170.13M

FY 2025 · Annual

Net Income

-$209.47M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.05M2.6M010M30.91M
Cost of Revenue00005.3M
Gross Profit2.05M2.6M010M25.62M
Gross Margin100.0%100.0%—100.0%82.9%
Research & Development39.35M50.56M61.36M81.33M114.6M
Selling, General & Admin24.12M24.98M30.73M43.62M81.15M
Operating Expenses63.46M75.53M92.08M124.96M195.75M
Depreciation & Amortization72K118K62K26K728K
EBITDA(61.16M)(71.56M)(83.17M)(125.86M)(207.61M)
EBITDA Margin-2978.9%-2756.4%—-1258.6%-671.6%
Operating Income(61.41M)(72.94M)(92.08M)(114.96M)(170.13M)
Operating Margin-2991.2%-2809.6%—-1149.6%-550.3%
Interest Income181K1.22M6.21M4.15M4.07M
Interest Expense9.97M2.14M4.14M4.56M1.14M
Other Income / Expenses(9.79M)(875K)4.72M(15.5M)(39.34M)
Income Before Tax(71.2M)(73.81M)(87.37M)(130.45M)(209.47M)
Pre-Tax Margin-3468.1%-2843.3%—-1304.5%-677.6%
Income Tax Expense000185K0
Net Income(71.2M)(73.81M)(87.37M)(130.64M)(209.47M)
Net Margin-3468.1%-2843.3%—-1306.4%-677.6%
EPS (Basic)(4.92)(4.57)(3.96)(3.66)(3.02)
EPS (Diluted)(4.92)(4.57)(3.96)(3.66)(3.02)
Weighted Avg Shares14.53M16.14M22.05M35.71M69.31M
Weighted Avg Shares (Diluted)14.53M16.14M22.05M35.71M69.31M

VSTM Earnings Waterfall · TTM

NASDAQ:VSTM · Revenue to Net Income

Key Ratios

EPS$-2.73
Gross Margin82.9%
Net Margin-618.4%
P/E Ratio-3.2
P/S Ratio62.6

Analysis

$49.6M of revenue converted into -$194.0M of net income for the selected period. Gross margin is 82.9% and net margin is -618.4%, showing how much revenue survives after costs and taxes. EPS is $-2.73, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
S-8S-8 filingNov 5, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipNov 5, 2026

How much revenue does VSTM generate?

Verastem, Inc. (VSTM) reported $30.91M of revenue in fiscal 2025.

Is VSTM profitable?

Verastem, Inc. (VSTM) reported -$209.47M of net income, with a net margin of -677.6%.